1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Hernández-Madrid A, Facchin D, Klepfer RN, Ghosh S, Matía R, Moreno J, Locatelli A.

    Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study.

    Heart Rhythm . 14(4): 541-547. Nº de citas: 14

    [doi:10.1016/j.hrthm.2017.01.022]

  • Millán Núñez-Cortés J, Cases Amenós A, Ascaso Gimilio JF, Barrios Alonso V, Pascual Fuster V, Pedro-Botet Montoya JC, Pintó Sala X, Serrano Cumplido A.

    Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.

    AM J CARDIOVASC DRUG . 17(2): 135-142. Nº de citas: 8

    [doi:10.1007/s40256-016-0197-9]

  • Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A.

    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.

    Circulation . 135(12): 1123-1132. Nº de citas: 136

    [doi:10.1161/CIRCULATIONAHA.116.025103]

  • Barrios D, Morillo R, Lobo JL, Nieto R, Jaureguizar A, Portillo AK, Barbero E, Fernandez-Golfin C, Yusen RD, Jiménez D, PROTECT investigators.

    Assessment of right ventricular function in acute pulmonary embolism.

    AMERICAN HEART JOURNAL . 185: 123-129. Nº de citas: 18

    [doi:10.1016/j.ahj.2016.12.009]

  • Chen J, Lenarczyk R, Boveda S, Richard Tilz R, Hernandez-Madrid A, Ptaszynski P, Pudulis J, Dagres N, conducted by the Scientific Initiative Committee, European Heart Rhythm Associat.

    Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey.

    EUROPACE . 19(2): 303-307. Nº de citas: 6

    [doi:10.1093/europace/eux001]

  • Barrios V, Escobar C, Cicero AF, Burke D, Fasching P, Banach M, Bruckert E.

    A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.

    ATHEROSCLEROSIS SUPPLEMENTS . 24: 1-15. Nº de citas: 62

    [doi:10.1016/j.atherosclerosissup.2016.10.003]

  • Barrios D, Rosa-Salazar V, Morillo R, Nieto R, Fernández S, Zamorano JL, Monreal M, Torbicki A, Yusen RD, Jiménez D.

    Prognostic Significance of Right Heart Thrombi in Patients With Acute Symptomatic Pulmonary Embolism: Systematic Review and Meta-analysis.

    Chest . 151(2): 409-416. Nº de citas: 33

    [doi:10.1016/j.chest.2016.09.038]

  • Saura D, Dulgheru R, Caballero L, Bernard A, Kou S, Gonjilashvili N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, Van De Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Gori AS, Cosyns B, Donal E, Habib G, Addetia K, Lang RM, Badano LP, Lancellotti P.

    Two-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 18(2): 167-179. Nº de citas: 51

    [doi:10.1093/ehjci/jew053]

  • Patti G, Lucerna M, Cavallari I, Ricottini E, Renda G, Pecen L, Romeo F, Le Heuzey JY, Zamorano JL, Kirchhof P, De Caterina R.

    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.

    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY . 69(4): 409-419. Nº de citas: 44

    [doi:10.1016/j.jacc.2016.10.069]

  • Val-Blasco A, Piedras MJ, Ruiz-Hurtado G, Suarez N, Prieto P, Gonzalez-Ramos S, Gómez-Hurtado N, Delgado C, Pereira L, Benito G, Zaragoza C, Domenech N, Crespo-Leiro MG, Vasquez-Echeverri D, Nuñez G, Lopez-Collazo E, Boscá L, Fernández-Velasco M.

    Role of NOD1 in Heart Failure Progression via Regulation of Ca 2+ Handling.

    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY . 69(4): 423-433. Nº de citas: 24

    [doi:10.1016/j.jacc.2016.10.073]

  • Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S, Authors/Task Force Members, Document Reviewers.

    2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

    EUROPEAN JOURNAL OF HEART FAILURE . 19(1): 9-42. Nº de citas: 161

    [doi:10.1002/ejhf.654]

  • Gámez JM, Masmiquel L, Ripoll T, Barrios V, Anguita M, SIRENA study.

    Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischaemic heart disease: Data from the SIRENA study.

    DIABETES RESEARCH AND CLINICAL PRACTICE . 123: 82-86. Nº de citas: 2

    [doi:10.1016/j.diabres.2016.11.019]

  • Marín F, Anguita Sánchez MP, Sanmartín Fernández M.

    Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.

    EXPERT OPINION ON PHARMACOTHERAPY . 18(1): 67-77. Nº de citas: 4

    [doi:10.1080/14656566.2016.1267140]

  • Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Terradellas JB, Carré F, Guasch E, Heidbuchel H, Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D, Reviewers:, Lip GY, Gorenek B, Lundqvist CB, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Marques-Vidal PM, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M.

    Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

    EUROPACE . 19(1): 139-163. Nº de citas: 42

    [doi:10.1093/europace/euw243]

  • Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradellas J, Carré F, Guasch E, Heidbuchel H, La Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D, Reviewers, Lip GY, Gorenek B, Blomström Lundqvist C, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Manuel Marques-Vidal P, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M.

    Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

    European journal of preventive cardiology . 24(1): 41-69. Nº de citas: 141

    [doi:10.1177/2047487316676042]

  • Barrios V, Masjuan J.

    Use of direct oral anticoagulants in patients with nonvalvular atrial fibrillation according to clinical profile.

    Future cardiology . 13(1): 49-64.

    [doi:10.2217/fca-2016-0061]

  • Barrios V, Kaskens L, Castellano JM, Cosin-Sales J, Ruiz JE, Zsolt I, Fuster V, Gracia A.

    Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.

    Revista espanola de cardiologia (English ed.) . 70(1): 42-49.

    [doi:10.1016/j.rec.2016.05.009]

  • Aquila I, Fernández-Golfín C, Rincon LM, González A, García Martín A, Hinojar R, Jimenez Nacher JJ, Indolfi C, Zamorano JL.

    Fully automated software for mitral annulus evaluation in chronic mitral regurgitation by 3-dimensional transesophageal echocardiography.

    Medicine . 95(49): . Nº de citas: 6

    [doi:10.1097/MD.0000000000005387]